Sitomni-M 50/500: Complete Guide to Sitagliptin + Metformin

Sitomni-M 50/500 is a prescription film-coated tablet marketed by EMK Omni Pharma, Mysuru, Karnataka. Each tablet contains Sitagliptin Phosphate IP equivalent to Sitagliptin 50 mg and Metformin Hydrochloride IP 500 mg, along with approved excipients.

The brand sits in the Diabetes Care category and is used only as part of a treatment plan set by a registered medical practitioner. The pack carries a Schedule G and Schedule H warning. In practical terms that means two things: it is dangerous to take this preparation except under medical supervision, and a chemist cannot sell it by retail without a prescription from a registered medical practitioner.

EMK Omni Pharma markets Sitomni-M 50/500. The tablets themselves are produced at GMP-certified contract manufacturing units and supplied under the EMK Omni Pharma label.

Type 2 diabetes is rarely caused by a single fault in the body, so this tablet brings together two molecules that act in different places.

Metformin Hydrochloride belongs to the biguanide class and has been the usual first medicine for type 2 diabetes for many years. Its main effect is to reduce the amount of glucose the liver releases into the bloodstream, especially overnight and between meals. It also helps muscle and fat tissue respond better to the insulin the body already produces. Metformin does not force the pancreas to release more insulin, which is why it seldom causes low blood sugar when used on its own.

Sitagliptin belongs to the DPP-4 inhibitor class. After a meal, the gut releases incretin hormones that signal the pancreas to release insulin and tell the liver to hold back glucagon. An enzyme called dipeptidyl peptidase-4 breaks those hormones down within minutes. Sitagliptin blocks that enzyme, so incretin activity lasts longer and the insulin response follows the meal more closely.

Because metformin works mainly on fasting glucose and sitagliptin mainly on the rise after eating, a fixed-dose combination lets a doctor address both patterns with one tablet instead of two.

Every carton and blister strip carries a batch number, manufacturing date, expiry date and MRP. Check all four before you accept a strip at the chemist counter, and keep the outer carton until the strip is finished.

Doctors generally consider a sitagliptin and metformin combination for adults with type 2 diabetes whose blood glucose is not sitting where it should be on diet, physical activity and a single medicine. Some people start on this combination after months on metformin alone. Others are moved to it when a doctor wants better cover for post-meal readings without a medicine that pushes blood sugar too low.

The 50/500 strength is one point on a range. A doctor may choose it for someone starting combination therapy, for an older patient, or for someone whose kidney function needs a lower metformin load.

This medicine is not used for type 1 diabetes and is not a treatment for diabetic ketoacidosis, which is a medical emergency. It also does not replace diet, weight management or exercise. Those remain part of the plan alongside any tablet.

This hub page is the starting point. The other articles in the series go deeper into one question each.

Book a review rather than adjusting anything yourself if your readings drift up or down, if you feel shaky, sweaty or confused, if you have persistent vomiting or diarrhoea, or if you notice deep and rapid breathing with unusual muscle pain and severe tiredness.

Tell your doctor before any surgery, before an X-ray or CT scan that uses iodinated contrast dye, if you are planning a pregnancy, or if you are unwell enough to stop eating and drinking normally. Also mention every other medicine, ayurvedic preparation or supplement you take, because some of them change how blood sugar behaves.

Do not stop Sitomni-M 50/500 on your own because you feel well. Blood sugar can rise quietly with no symptoms at all. This article is for general information only and is not a substitute for advice from a registered medical practitioner.